ENTITY

Rigel Pharmaceuticals (RIGL US)

Health CareUnited States
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. The Company's research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.
more
Company Presentation08 Nov 2024 05:30
Company Presentation07 Aug 2024 04:30
Company Presentation08 May 2024 04:30
Company Presentation06 Mar 2024 05:30
Company Presentation15 Dec 2023 00:00
x